Abstract 372: Loss of RB1 sensitizes TP53-mutated cancer cells to WEE1 inhibition by azenosertib
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Daehwan Kim, Olivier Harismendy, Catherine Lee, Erika Cabrera, Danielle Jandial, Doris Kim, Mark R. Lackner, Jianhui Ma
Institution: Zentalis Pharmaceuticals (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409690578